STENOCARE A/S announced that it has received approval from The Danish Medicines Agency to sell a new medical cannabis oil product to Danish patients. With this, STENOCARE once again becomes the only supplier of medical cannabis oil products under the Danish Pilot Programme. The product is called "THC Olie STENOCARE" and contains 30 mg/mL THC.

The new product has been examined by The Danish Medicines Agency for compliance with the Danish Pilot Programme and its strict quality standards. After a very thorough process, the product has now been accepted into the Danish program. The new product from STENOCARE becomes the first and only oil product available for patients under the Programme.

It is expected that the new product will be available for patients during First Quarter 2022 pending international import and export certificates. STENOCARE is working with the Danish Medicines Agency to have further two products approved for the Pilot Programme, and the products are a CBD oil and a mixed THC-CBD oil.